Provided by Tiger Trade Technology Pte. Ltd.

Illumina

117.67
-6.7300-5.41%
Post-market: 117.00-0.6700-0.57%19:53 EDT
Volume:1.22M
Turnover:144.75M
Market Cap:17.98B
PE:21.59
High:123.32
Open:123.00
Low:116.74
Close:124.40
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.83
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:6.60
PE(LYR):21.59

Loading ...

BRIEF-Illumina Constellation Mapped Read Technology Uncovers Hard-To-See Genomic Insights In GeneDx Pilot

Reuters
·
Oct 15, 2025

Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics

Reuters
·
Oct 15, 2025

Illumina Constellation Mapped Read Technology Uncovers Hard-to-See Genomic Insights in GeneDx Pilot

THOMSON REUTERS
·
Oct 15, 2025

Illumina Inc - Constellation-Based Product Release Slated for First Half of 2026

THOMSON REUTERS
·
Oct 15, 2025

Illumina Unveils 5-Base Solution Enabling Simultaneous Genomic and Epigenomic Analysis for Rare Disease Research

Reuters
·
Oct 15, 2025

Illumina Fuels Multiomic Discovery With Launch of 5-Base Solution, Unlocking Simultaneous Genomic and Epigenomic Insights

THOMSON REUTERS
·
Oct 15, 2025

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns

Benzinga_recent_news
·
Oct 15, 2025

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

THOMSON REUTERS
·
Oct 15, 2025

Stock Track | Illumina Stock Plummets 5.11% as China's Ban on Genetic Sequencers Intensifies Trade War Impact

Stock Track
·
Oct 14, 2025

Stock Track | Illumina Shares Plummet 5.11% as China Bans Import of Company's Genetic Sequencers

Stock Track
·
Oct 14, 2025

Illumina Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Oct 08, 2025

Illumina (ILMN) Gets a Sell from Citi

TIPRANKS
·
Oct 07, 2025

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Guardant Health (GH)

TIPRANKS
·
Oct 07, 2025

1 Volatile Stock to Target This Week and 2 Facing Headwinds

stock_story_highlight
·
Oct 07, 2025

Illumina Is Maintained at Underweight by Barclays

Dow Jones
·
Oct 02, 2025

GeneDx and Partners Secure $14.4M NIH Grant to Launch First U.S. Multi-State Genomic Newborn Screening Initiative

Reuters
·
Oct 02, 2025

BRIEF-Illumina Launches New Business To Accelerate Technology And Data-Driven Discovery

Reuters
·
Oct 01, 2025

Stock Track | Illumina Soars 5.05% as New AI-Driven Business BioInsight Launches

Stock Track
·
Oct 01, 2025

Illumina Inc - Launches Bioinsight

THOMSON REUTERS
·
Oct 01, 2025